DrugPatentWatch Database Preview
TOTECT Drug Profile
Which patents cover Totect, and when can generic versions of Totect launch?
Totect is a drug marketed by Clinigen Hlthcare and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-two patent family members in sixteen countries.
The generic ingredient in TOTECT is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Summary for TOTECT
| International Patents: | 22 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 43 |
| Clinical Trials: | 3 |
| Patent Applications: | 167 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TOTECT |
| DailyMed Link: | TOTECT at DailyMed |
Pharmacology for TOTECT
| Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for TOTECT
Synonyms for TOTECT
| (+)-Razoxane hydrochloride |
| (S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione hydrochloride |
| (S)-4,4'-(propane-1,2-diyl)bis(piperazine-2,6-dione) hydrochloride |
| 003D010 |
| 1263283-43-7 |
| 149003-01-0 |
| 2,6-Piperazinedione, 4,4'-((1S)-1-methyl-1,2-ethanediyl)bis-, hydrochloride (1:1) |
| 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, hydrochloride, (S)- |
| 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride |
| 5346058Q7S |
| AC-9014 |
| AC1OCF6D |
| ADR-529 |
| ADR-529 hydrochloride |
| AKOS015900046 |
| AN-7454 |
| AOB6763 |
| AOB6863 |
| API0005176 |
| AS-16976 |
| C11H16N4O4.HCl |
| Cardioxane |
| CHEBI:50224 |
| CHEMBL1200778 |
| CS-0767 |
| D07807 |
| Dexrazoxane (Hydrochloride) |
| Dexrazoxane (TN) |
| Dexrazoxane HCl |
| Dexrazoxane hydrochloride |
| Dexrazoxane hydrochloride [ORANGE BOOK] |
| Dexrazoxane hydrochloride [VANDF] |
| Dexrazoxane hydrochloride [WHO-DD] |
| DTXSID60164152 |
| FT-0700082 |
| HY-76201 |
| I14-10061 |
| ICRF 187 hydrochloride |
| ICRF-187 hydrochloride |
| KDX-0811 |
| MolPort-023-276-958 |
| Razoxane (+)-form hydrochloride [MI] |
| Razoxane hydrochloride, (S)- |
| s1222 |
| Savene |
| Savene (TN) |
| SCHEMBL18188 |
| TopoTect |
| Totect (TN) |
| UNII-5346058Q7S |
| UNII-BR9T89F617 component BIFMNMPSIYHKDN-FJXQXJEOSA-N |
| W-5214 |
| X5010 |
| Zinecard |
| Zinecard (TN) |
US Patents and Regulatory Information for TOTECT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinigen Hlthcare | TOTECT | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 022025-001 | Sep 6, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for TOTECT
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Denmark | 1162981 | ➤ Sign Up |
| Spain | 2220424 | ➤ Sign Up |
| Hong Kong | 1043054 | ➤ Sign Up |
| European Patent Office | 1162981 | ➤ Sign Up |
| Japan | 4422916 | ➤ Sign Up |
| Australia | 769533 | ➤ Sign Up |
| Brazil | 0009473 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
